基于语音的数字生物标志物用于阿尔茨海默病研究
Simona Schäfer1, Janna Herrmann1, Sol Tovar1
1ki:elements GmbH, Saarbrücken, Germany.
Methods in molecular biology (Clifton, N.J.)
|March 1, 2024
概括
语音分析为阿尔茨海默病 (AD) 研究提供了一个有希望的,低负担的方法. 本章详细介绍了收集和处理语音数据的方法,以创建用于AD临床研究的有价值的基于语音的数字生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 数字健康数字健康
- 生物标志物研究 生物标志物研究
背景情况:
- 数字生物标志物在阿尔茨海默病 (AD) 研究中越来越重要.
- 语音数据提供客观的,远程评估AD症状和认知与最小的患者负担.
- 在收集,准备和解释用于临床研究的语音数据方面存在挑战.
研究的目的:
- 概述创建有效语音收集场景所需的方法.
- 为了使AD临床研究能够生成有价值的基于语音的数字生物标志物.
主要方法:
- 使用专门的管道来收集语音.
- 实施数据分析的预处理步骤和算法.
- 专注于精确的资格和定量AD病理学从言语.
主要成果:
- 描述的方法有助于从语音数据中提取有意义的见解.
- 在现实环境中进行更客观,更准确的患者评估的潜力.
- 能够进行多式差异分析,预测个体疾病进展.
结论:
- 标准化的语音收集和分析方法对于AD研究至关重要.
- 基于语音的数字生物标志物可以显著提高对阿尔茨海默病的理解和监测.
- 这种方法支持远程数据收集和个性化疾病进展建模.
相关概念视频
01:26Alzheimer's Disease: Overview
481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481
01:22Alzheimer's Disease: Treatment
188
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
188